SPIA
SUPN icon

Steward Partners Investment Advisory’s Supernus Pharmaceuticals SUPN Stock Holding History

Steward Partners Investment Advisory’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-29
Closed -$1.39K – 4462
2025
Q3 		$1.39K Buy
+29
New +$1.17K ﹤0.01% 4000
2024
Q3 		– Sell
-117
Closed -$3.13K – 3845
2024
Q2 		$3.13K Hold
117
– – ﹤0.01% 3178
2024
Q1 		$3.99K Hold
117
– – ﹤0.01% 3112
2023
Q4 		$3.39K Hold
117
– – ﹤0.01% 3097
2023
Q3 		$3.23K Hold
117
– – ﹤0.01% 2960
2023
Q2 		$3.52K Hold
117
– – ﹤0.01% 2901
2023
Q1 		$4.24K Hold
117
– – ﹤0.01% 2830
2022
Q4 		$4.17K Sell
117
-25
-18% -$869 ﹤0.01% 2827
2022
Q3 		$5K Buy
142
+25
+21% +$814 ﹤0.01% 2786
2022
Q2 		$3K Hold
117
– – ﹤0.01% 2948
2022
Q1 		$4K Hold
117
– – ﹤0.01% 2981
2021
Q4 		$3K Sell
117
-15
-11% -$455 ﹤0.01% 2966
2021
Q3 		$4K Hold
132
– – ﹤0.01% 2882
2021
Q2 		$4K Sell
132
-500
-79% -$15.3K ﹤0.01% 6711
2021
Q1 		$16.5K Buy
632
+500
+379% +$14K ﹤0.01% 2561
2020
Q4 		$3K Hold
132
– – ﹤0.01% 2654
2020
Q3 		$3K Hold
132
– – ﹤0.01% 2523
2020
Q2 		$3K Sell
132
-101
-43% -$2.23K ﹤0.01% 2414
2020
Q1 		$4K Sell
233
-200
-46% -$4.2K ﹤0.01% 2161
2019
Q4 		$10K Sell
433
-200
-32% -$4.86K ﹤0.01% 2027
2019
Q3 		$17K Buy
633
+15
+2% +$444 ﹤0.01% 1788
2019
Q2 		$20K Buy
+618
New +$21.2K ﹤0.01% 1716
2018
Q4 		– Sell
-317
Closed -$16K – 1988
2018
Q3 		$16K Buy
317
+200
+171% +$9.88K ﹤0.01% 1665
2018
Q2 		$7K Hold
117
– – ﹤0.01% 1892
2018
Q1 		$5K Hold
117
– – ﹤0.01% 1806
2017
Q4 		$4K Hold
117
– – ﹤0.01% 1584
2017
Q3 		$4K Hold
117
– – ﹤0.01% 1364
2017
Q2 		$5K Hold
117
– – ﹤0.01% 1232
2017
Q1 		$3K Buy
+117
New +$3.13K ﹤0.01% 1257

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Steward Partners Investment Advisory's SUPN Position: Q4 2025 in Review

Steward Partners Investment Advisory sold out of Supernus Pharmaceuticals (SUPN) in Q4 2025, closing a stake of 29 shares — an estimated $1.39K sold.

Steward Partners Investment Advisory first reported a position in SUPN in Q1 2017 and held it in 29 quarters. The position peaked at $20K in Q2 2019. 333 funds tracked by Wall St. Rank hold SUPN as of Q4 2025.

  • Steward Partners Investment Advisory reported no remaining Supernus Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 29 Supernus Pharmaceuticals shares in Q4 2025, an estimated $1.39K.
  • Steward Partners Investment Advisory first reported a position in Supernus Pharmaceuticals in Q1 2017 and held it in 29 quarters.
  • Steward Partners Investment Advisory's Supernus Pharmaceuticals position peaked at $20K in Q2 2019.
  • 333 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2025.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2025, filed 12 Feb 2026.